Background
Moyamoya disease includes spontaneous occlusion of the vessels of the Circle of Willis, and was first described in Japan in 1957, but later named in 1969 after the Japanese term for 'puff of smoke,' to describe the imaging appearance seen on angiography [1, 2] . In Japan, moyamoya disease has a very low incidence of 0.35 per 100,000, and its incidence is even lower in the United States, at 0.086 per 100,000 [3, 4] . Treatment for moyamoya disease is surgical and involves either direct or indirect revascularization [5] .
Cerebral hyperperfusion syndrome is a complication of the revascularization procedures required for the treatment of moyamoya disease [6] . Hyperperfusion syndrome results in symptoms of increased intracranial pressure (ICP), most likely due to the sudden increase in cerebral blood flow. In patients treated for moyamoya disease, the complication of hyperperfusion syndrome has been reported mainly in adult patients and those treated with a direct revascularization procedure [6, 7] .
We present a case of an 18-month-old girl with moyamoya disease that was treated with bilateral pial synangiosis with complications consistent with cerebral hyperperfusion syndrome. This case report discusses the pathophysiological mechanisms involved in cerebral hyperperfusion and moyamoya syndrome.
Case Report
An 18-month-old Caucasian female presented with seizures and weakness of the left side during late October. Diagnostic imaging with angiography confirmed bilateral moyamoya disease that was worse on the right side (Figures 1, 2) . Due to the small diameter of the superficial temporal arteries, direct revascularization was not an option for the patient.
Indirect revascularization with pial synangiosis was first performed on the right side in December of the same year. Angiography was performed postoperatively and showed viable collaterals and increased rate of occlusion of the right internal carotid artery (ICA) following the procedure. Also following the first procedure, the patient developed a sub-galea fluid collection over the incision site, but this resolved spontaneously.
Pial synangiosis was then performed on the left side in May of the following year, to allow for healing and maturation of first procedure. Angiography performed postoperatively showed viable collateral vessels. After the second procedure, the patient again developed a fluid collection, but this time, over the second incision site, which eventually leaked and became infected with Pseudomonas aeroginosa. This infected fluid collection required surgical washout and treatment with intravenous (IV) cefepime. During the washout procedure, ultrasound imaging was used and showed viable collateral vessels associated with the left-sided anastomosis, four weeks after the procedure ( Figure 3A, 3B ).
In addition to the fluid collection, the patient also experienced new left-sided headaches, which, together with the repeated fluid collections, were due to elevated intracranial pressure (ICP). The patient was diagnosed with cerebral hyperperfusion 
Discussion
Treatment for moyamoya disease is surgical and involves either a direct or indirect revascularization [5] . Direct revascularization involves anastomosis to the middle cerebral artery (MCA) and provides immediate benefit [5] . Indirect revascularization requires the mobilization of vascularized tissue and their placement in contact with the pia to allow new vessels to form and can take between three and four months for benefit to develop [5] . New surgical techniques for moyamoya disease now involve a combination of both indirect and direct revascularization [5] .
Cerebral hyperperfusion syndrome is a complication of the revascularization procedures that are required for the treatment of moyamoya disease [6] . Cerebral hyperperfusion syndrome has a multifactorial etiology that includes impaired autoregulation of cerebral blood flow, damage to the blood-brain barrier, free radical damage, and baroreceptor dysfunction [8] . In patients treated for moyamoya disease, the complication of cerebral hyperperfusion syndrome has been reported mainly in adult patients and those treated with direct revascularization procedures, but not in children and those treated with an indirect revascularization [6, 9] . The treatment of cerebral hyperperfusion syndrome usually involves strict blood pressure control [9] . In this case, the patient's intracranial pressure (ICP) remained elevated in spite of well-controlled blood pressure and was ultimately treated with a lumbar shunt. This case is an example of a pediatric patient with moyamoya disease who developed cerebral hyperperfusion syndrome following indirect revascularization, which we believe to be a previously unreported association [9] . Recognition of the possible complication of cerebral hyperperfusion syndrome in this population is important for their postoperative care. We suggest more studies be done to determine the possible risk factors and causes of this complication in the pediatric population with moyamoya disease.
A further finding of interest in this case was the increased progression of vascular occlusion following the revascularization procedure on the right side. A possible reason for the increased progression of vascular occlusion may be a decrease in the production of angiogenic factors due to improved blood flow to the brain parenchyma from the revascularization procedure [10] . Previous studies have used imaging with transcranial Doppler (TCD) to diagnose moyamoya disease, and TCD could be used in the follow-up of patients following revascularization procedures [10] . Future studies should be performed that include measurement and comparison of flow using TCD of the affected vessel and collaterals before and after revascularization to investigate the mechanisms of hyperperfusion syndrome and vascular occlusion.
Conclusions
This report has presented a pediatric case of cerebral hyperperfusion syndrome as a complication of moyamoya disease. Although the patient progressed well after placement of a lumbar shunt, this case demonstrates the occurrence of cerebral hyperperfusion syndrome as a complication of revascularization in pediatric patients and highlights the need for further research in this area.
